These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5853251)

  • 21. Alteration of rat skin acid and alkaline phosphatase and beta-glucuronidase activity after topical application of fluocinolone acetonide cream.
    Di Pasquale G; Manning JP
    J Pharm Pharmacol; 1970 Aug; 22(8):642-3. PubMed ID: 4394551
    [No Abstract]   [Full Text] [Related]  

  • 22. The activity of fluocinonide on diseases and healthy skin in comparison with other topical corticosteroids.
    Kalkoff KW
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):51-6. PubMed ID: 5291633
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of seborrhea capitis with fluocinolone acetonide in propylene glycol: a clinical report.
    Yarborough JM; Burks JW
    J La State Med Soc; 1967 Jul; 119(7):290-1. PubMed ID: 4229894
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester.
    Poulsen BJ; Young E; Coquilla V; Katz M
    J Pharm Sci; 1968 Jun; 57(6):928-33. PubMed ID: 5671339
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of 0.01 per cent solution of fluocinolone acetonide in propylene glycol].
    Aceves Ortega R
    Medicina (Mex); 1965 Apr; 45(962):171-6. PubMed ID: 5837268
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of Flucort solution on eczema lesions].
    Kotani Y
    Acta Dermatol Kyoto Engl Ed; 1967 Aug; 62(3):209-14. PubMed ID: 5631426
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. A direct comparison.
    Stoughton RB
    Arch Dermatol; 1969 Jun; 99(6):753-6. PubMed ID: 5814595
    [No Abstract]   [Full Text] [Related]  

  • 28. Propylene glycol as a vehicle for percutaneous absorption of therapeutic agents.
    Bailey DN
    J Anal Toxicol; 1992; 16(2):97-8. PubMed ID: 1380108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base.
    Burdick KH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):24-31. PubMed ID: 5291631
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical pharmacology of locally applied glucocorticoids.
    Raab WP
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):32-9. PubMed ID: 5004480
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with fluocinonide FAPG].
    Reiffenstuhl B; Wolf D
    Wien Med Wochenschr; 1973 Sep; 123(38):555-6. PubMed ID: 4270843
    [No Abstract]   [Full Text] [Related]  

  • 32. THERAPEUTIC EFFICACY OF FLUOCINOLONE ACETONIDE OINTMENT AND CREAM.
    BLEIBERG J; BRODKIN RH
    Arch Dermatol; 1964 Apr; 89():561. PubMed ID: 14107624
    [No Abstract]   [Full Text] [Related]  

  • 33. Extemporaneous formulation of corticosteroids for topical usage.
    Burdick KH; Poulsen B; Place VA
    JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919
    [No Abstract]   [Full Text] [Related]  

  • 34. [Further observations with fluocinolone acetonide in local administration].
    Gatti JC; Cardama JE; Avila JJ; Carnevale Benino de Gar
    Prensa Med Argent; 1966 Sep; 53(35):1919-20. PubMed ID: 6011708
    [No Abstract]   [Full Text] [Related]  

  • 35. Ultraviolet-induced cutaneous hyperemia and steroid-induced cutaneous hypoemia measured by xenon 133 disappearance in dogs.
    Chimoskey JE; Flanagan W
    J Invest Dermatol; 1974 Oct; 63(4):362-6. PubMed ID: 4472541
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of steroids on fibroblasts. I. An in vitro fibroblast assay for corticosteroids.
    Berliner DL; Ruhmann AG
    J Invest Dermatol; 1967 Aug; 49(2):117-22. PubMed ID: 6037577
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity.
    Reid J; Brookes DB
    Br J Dermatol; 1968 May; 80(5):328-36. PubMed ID: 4873078
    [No Abstract]   [Full Text] [Related]  

  • 38. Vehicle effects on in vitro percutaneous absorption through rat and human skin.
    Hilton J; Woollen BH; Scott RC; Auton TR; Trebilcock KL; Wilks MF
    Pharm Res; 1994 Oct; 11(10):1396-400. PubMed ID: 7855041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 40. Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro.
    Zesch A; Schaefer H
    Acta Derm Venereol; 1974; 54(2):91-7. PubMed ID: 4133027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.